The SMYD3 gene helps control when other genes are switched on or off, which supports normal cell growth and repair. If the SMYD3 gene does not work normally, that control can become less steady, and cells may grow or survive in ways that raise the chance of cancer. This gene plays an important role in tissues where cells are dividing and renewing. SMYD3 is mainly known in cancer research rather than in public awareness campaigns or celebrity stories.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to make proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they operate. Overall, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. To explore this topic in more depth, you can read more in the LearnHub.
Overview
SMYD3Gene function
What if the gene works
The SMYD3 gene helps control which genes are turned on or off. Its protein adds small chemical tags to proteins that organize DNA, supporting normal cell growth and tissue development.
Risk
What if the gene does not work
Milder to more severe variants in the SMYD3 gene can reduce how well cells switch certain genes on and off. This may weaken its protein-marking activity and disrupt growth and repair signaling inside cells.
Treatment
What does that mean for your treatment
No SMYD3-specific treatment or management approach is currently established for people with a pathogenic variant in the SMYD3 gene. In research settings, the SMYD3 gene is being studied as a possible drug target and tumor marker in several cancers, but this has not yet changed routine treatment choices.
Gene function
What if the gene works
Your cells need the right instructions to be used at the right time. The SMYD3 gene helps manage that timing by placing small chemical tags on proteins that package DNA. This helps certain genes become easier for the cell to read and use.
The SMYD3 gene adds small chemical tags to histones (proteins that DNA wraps around). This is one of the main ways the SMYD3 gene helps control gene activity.
These tags can shape local DNA packing so selected stretches are easier for cells to read. That supports orderly use of genetic instructions during normal growth and everyday cell upkeep.
SMYD3 also works with parts of the cell that copy active genes into RNA (a working message made from DNA). This helps gene use stay organized from reading DNA to making usable messages.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help account for normal differences among people, such as appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
SMYD3 gene variants can change the protein’s shape, stability, or ability to attach to its usual targets, which may reduce or alter its marking activity inside the cell. Some variants have a mild effect, while more severe variants can greatly lower protein levels or stop the protein from working at all. This helps explain how SMYD3 gene variants affect protein function at the cellular level.
How variants are linked to conditions
SMYD3 does not yet have a broadly confirmed link to a specific health condition, though research on SMYD3 gene variants linked to conditions is still developing. Anyone with a confirmed SMYD3-related finding should rely on guidance from their doctor or genetic counselor for personal interpretation.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors contribute. In some cases, however, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SMYD3 gene. If you have concerns about your personal or family risk, a doctor or genetic counselor can help put any test result in context.
Inheritance of SMYD3 variants
There is not yet a broadly confirmed inheritance pattern tied to a specific human condition for the SMYD3 gene, so how SMYD3 gene variants are inherited in a disease causing way is still being worked out. The SMYD3 gene is located on chromosome 1, which is an autosome. That means each person usually inherits one copy of the SMYD3 gene from each parent, regardless of sex.
What does my SMYD3 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific inherited condition for SMYD3. If you have a SMYD3 result and want to understand what it could mean for parents, siblings, or children, a doctor or genetic counselor can help interpret it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
People looking into how to test for variants in the SMYD3 gene usually have DNA checked from a blood or saliva sample, and the lab compares the SMYD3 gene sequence with the usual reference sequence. Results may identify a known variant, no relevant change, or a variant of uncertain significance, which means the effect on health is not yet clear.
When should I consider getting a genetic test?
There is not yet a broadly established, SMYD3-specific clinical reason for genetic testing in routine care. Testing decisions are usually based on your personal health history, family history, and the guidance of a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may absorb, break down, or respond to a drug in different ways. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics focuses on how genetic differences affect responses to medications. By examining links between genes and drugs, it aims to explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. That knowledge can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the SMYD3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose. If you have concerns about side effects, how well a treatment is working, or medicine safety, talk with your doctor or pharmacist.
History
In the early 2000s, researchers identified the SMYD3 gene while studying genes active in cancer cells. Initial reports drew attention because SMYD3 appeared to be more active in some colorectal, liver, and breast tumors than in nearby noncancer tissue. From these first observations, research expanded steadily, and SMYD3 became part of a broader effort to understand how changes in gene control can influence cancer development. Over time, descriptions became more precise as laboratory studies mapped where SMYD3 is active and how it affects cell growth. While it never became a high profile public gene, it gained a clear place in cancer research as scientists refined the picture of genes involved in tumor biology.